Could statins represent a new frontier for improving outcomes with neoadjuvant chemotherapy in hormone receptor-positive, HER2-negative breast cancer

Could statins represent a new frontier for improving outcomes with neoadjuvant chemotherapy in hormone receptor-positive, HER2-negative breast cancer

Hormone receptor-positive, HER2-negative breast cancer represents a significant subset of breast cancer patients, many of whom undergo neoadjuvant therapy. However, treatment responses in this patient population are often suboptimal. In our study, we aimed to investigate the potential contribu...